Hansoh Pharmaceutical Group Company Limited (HK:3692) has released an update.
Hansoh Pharmaceutical Group Company Limited has announced the grant of restricted share units (RSUs) totaling 11,397,590 shares to 616 grantees under its Post-IPO RSU Scheme. The grants, which include shares for two executive directors and 614 employees, will vest over a three-year period starting June 27, 2024, contingent on meeting specific performance targets. No new shares will be issued for the vesting of these RSUs, as they form part of the remuneration package for the executive directors.
For further insights into HK:3692 stock, check out TipRanks’ Stock Analysis page.
